Lazard International Equity Select Portfolio OCSE:NOVO B Holdings History
Lazard International Equity Select Portfolio's Novo Nordisk AS Holding Summary
As of 2025-03-31, LAZARD FUNDS INC held 11,985.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr830,710.00. This investment constitutes 1.65% of their stock portfolio, and LAZARD FUNDS INC now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2023Q2. And since then Lazard International Equity Select Portfolio has made 3 purchases of OCSE:NOVO B, at an average price of kr593.12, for a total of 16,109.00 shares. In addition, there have been 3 sales at an average price of kr811.59 for 4,124.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, Lazard International Equity Select Portfolio's estimated gain on his OCSE:NOVO B holdings is kr-798,701.10, reflecting a -8.36% gain to date.
Lazard International Equity Select Portfolio OCSE:NOVO B (kr451.30) Holding Chart
Lazard International Equity Select Portfolio OCSE:NOVO B (kr451.30) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price kr-/Share | ||
Shares Sold | 0 | Average Price kr-/Share | ||
Current Price kr0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1